CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 442 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,515,069 | +19.7% | 102,112 | +51.0% | 0.17% | +20.3% |
| Q1 2024 | $4,608,434 | +0.1% | 67,612 | -8.1% | 0.14% | -9.5% |
| Q4 2023 | $4,603,416 | +14.3% | 73,537 | -17.1% | 0.16% | +1.9% |
| Q3 2023 | $4,026,865 | +17.9% | 88,717 | +45.8% | 0.16% | +23.0% |
| Q2 2023 | $3,415,670 | +227.2% | 60,842 | +136.9% | 0.13% | +180.0% |
| Q4 2022 | $1,043,973 | -72.6% | 25,682 | -56.0% | 0.04% | -75.3% |
| Q3 2022 | $3,815,000 | -28.0% | 58,382 | -33.0% | 0.18% | -23.8% |
| Q2 2022 | $5,296,000 | -2.1% | 87,152 | +1.1% | 0.24% | +21.3% |
| Q1 2022 | $5,408,000 | -39.7% | 86,163 | -27.2% | 0.20% | -33.4% |
| Q4 2021 | $8,969,000 | -32.6% | 118,352 | -0.5% | 0.30% | -40.9% |
| Q3 2021 | $13,311,000 | -29.8% | 118,927 | +1.5% | 0.50% | -30.0% |
| Q2 2021 | $18,969,000 | +42.2% | 117,172 | +7.0% | 0.72% | +28.1% |
| Q1 2021 | $13,340,000 | -7.5% | 109,481 | +16.2% | 0.56% | -13.7% |
| Q4 2020 | $14,422,000 | +93.2% | 94,192 | +5.5% | 0.65% | +69.6% |
| Q3 2020 | $7,466,000 | +10.8% | 89,265 | -2.7% | 0.38% | -1.5% |
| Q2 2020 | $6,741,000 | +139.9% | 91,720 | +38.4% | 0.39% | +99.0% |
| Q1 2020 | $2,810,000 | +22.7% | 66,260 | +76.2% | 0.20% | +47.7% |
| Q4 2019 | $2,291,000 | +122.0% | 37,610 | +49.4% | 0.13% | +100.0% |
| Q3 2019 | $1,032,000 | -3.0% | 25,170 | +11.4% | 0.07% | -4.3% |
| Q2 2019 | $1,064,000 | – | 22,600 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |